Please login to the form below

Not currently logged in
Email:
Password:

Michael Zaiac moves from GSK to Celgene

He takes up the role of VP, medical affairs, haematology-oncology EMEA

Celgene Michael ZaiacCelgene has appointed Michael Zaiac as vice president, medical affairs for its EMEA haematology-oncology business.

Zaiac joins the company's Switzerland-based international business from GlaxoSmithKline, where he was most recently franchise medical head for its immuno-inflammation and infectious diseases operations.

Prior to joining the pharmaceutical industry Zaiac served for several years as senior house officer in the UK in general, orthopaedic and cardiothoracic surgery, as well as working in Germany in general and vascular surgery and surgical oncology.

Marie-France Tschudin, corporate vice president of haematology-oncology at Celgene International, said “I am really pleased to have Michael on board to head up our haematology-oncology medical affairs team.

“This is a really exciting time for Celgene in EMEA, with three European approvals already in 2015, two of which are in haematology-oncology. His expertise in this area will give us the strong support we need at this fast-moving time.”

13th May 2015

From: Regulatory

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Bedrock Group

Bedrock Healthcare Communications is a privately owned, award winning communications agency that creates and delivers highly effective, insight driven medical...

Latest intelligence

#DemandDiversity: For International Women's Day, we ask... why do women often suffer from more side effects than men?
Women are largely prescribed exactly the same treatment regimens as men, with no account for the underlying differences in physiology and drug metabolism between the sexes....
Good design saves lives
Good design and creative thinking are essential if we are to improve on existing problems in new ways, which is why design and creativity within healthcare is vital. Health is...
Why you must understand the pricing of patient recruitment companies
Recruiting a diverse range of patients and engaging with them for your clinical trial isn’t an easy task, which means you might turn to patient recruitment companies, like us, who...

Infographics